Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology
Reference20 articles.
1. Yates, C., & Manini, A. F. (2012). Utility of the electrocardiogram in drug overdose and poisoning: Theoretical considerations and clinical implications. Current Cardiology Reviews, 8(2), 137–151.
2. Woosley, R. L., Heise, C. W., & Romero, K. A. (2018). QTdrugs list, AZCERT, Inc. 1822 Innovation Park Dr., Oro Valley, AZ 85755 Retrieved July 6, 2018, from www.Crediblemeds.org
3. Drew, B. J., Ackerman, M. J., Funk, M., Gibler, W. B., Kligfield, P., Menon, V., Philippides, G. J., Roden, D. M., Zareba, W., American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology, the Council on Cardiovascular Nursing, and the American College of Cardiology Foundation. (2010). Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation, 121(8), 1047–1060.
4. Tisdale, J. E., Jaynes, H. A., Kingery, J. R., Overholser, B. R., Mourad, N. A., Trujillo, T. N., & Kovacs, R. J. (2014). Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients. Circulation Cardiovascular Quality and Outcomes, 7(3), 381–390.
5. Isbister, G. K. (2015). Risk assessment of drug-induced QT prolongation. Australian Prescriber, 38(1), 20–24.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献